Brief: Hemostemix Inc. Announces agreement to resolve all outstanding matters with Hemostemix (Asia) Corporation (HEMA)
17/08/2017 20:20
Aug 17 (Reuters) - Hemostemix Inc HEM.V
* Hemostemix - HEMA'S litigation will be discontinued on without costs basis
and strategic alliance between co, HEMA will be terminated
* Hemostemix Inc. Announces agreement to resolve all outstanding matters
with hemostemix (asia) corporation (HEMA)
* Hemostemix Inc - reached deal with Hemostemix (Asia) Corp to resolve
matters with HEMA including litigation against company being carried on by HEMA
* Hemostemix Inc - pursuant to agreement, subject only to receipt of
payments, HEMA will release all claims against company
Source text for Eikon: ID:nGNXODDFLa
Further company coverage: HEM.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update